Neurotechnique A Chemical-Genetic Approach to Studying Neurotrophin Signaling
By X. Chen, Haihong Ye, R. Kuruvilla, N. Ramanan, K. Scangos, Chao Zhang, N. Johnson, Pamela M England, Kevan M. Shokat, D. Ginty. 2005
240 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/0e7b1cd1f61ee90d772a61dcb345d08107d61ad4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Manuel Yepes
- K. Ye
- Xia Liu
- Y. Sun
- Yang Liu
- Solomon H. Snyder
- W. David Wilson
- G. Miller
Citations in the corpus
- A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. (2006, unknown): “This approach has been successful both in cultured cells and in mice (Bishop et al., 2000; Wang et al., 2003, Chen et al., 2005); however, it is limited to ATPases and GTPases.”
- DREADDs for Neuroscientists (2016, methodology): “Over the past two decades, a large number of chemogenetic (also known as “chemical genetic”; (Bishop et al., 1998; Strader et al., 1991; Chen et al., 2005; Sternson and Roth, 2014) platforms have been invented that have been useful for biologists in general and most especially for neuroscientists.”
- Direct current stimulation promotes BDNF-dependent synaptic plasticity: Potential implications for motor learning (2010, unknown): “In TrkBF616A knockin mice, the endogenous TrkB gene is replaced by TrkBF616A, so that TrkB kinase activity can be selectively inhibited by the membrane-permeable small molecule 1NMPP1 (Chen et al., 2005).”
- A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone (2010, background): “TrkB F616A knockin mice, when treated with 1NMPP1, exhibit an effective TrkB-null phenotype (15).”